FDA To Review AstraZeneca Diabetes Drug For Heart Risks
The U.S. Food and Drug Administration launched an investigation Tuesday into the safety of an AstraZeneca PLC diabetes drug after a recent study found that users of the medication were more...To view the full article, register now.
Already a subscriber? Click here to view full article